Stromal upregulation of SOX2 promotes tumorigenesis through the generation of a SFRP1/2-expressing cancer-associated fibroblast population

SUMMARY Cancer-associated fibroblasts (CAFs) promote tumor malignancy, but the precise transcriptional mechanisms regulating the acquisition of the CAF phenotype are not well understood. We show that the upregulation of SOX2 is central to this process, which is repressed by protein kinase C ζ (PKC ζ ). PKC ζ deficiency activates the reprogramming of colonic fibroblasts to generate a predominant SOX2-dependent CAF population expressing the WNT regulator Sfrp2 as its top biomarker. Therefore, the PKC ζ -SOX2 axis emerges as a critical step in the control of CAF pro-tumorigenic potential. eTOC Kasashima et al. describe a molecular mechanism whereby the loss of PKCz in the stroma upregulates SOX2 to activate the reprogramming of colonic fibroblasts generating a SFRP1/2-expressing CAF population. This population supports epithelial tumor progression, revealing vulnerabilities in mesenchymal CMS4 colorectal cancer. role of the in phenotype in show that PKC ζ , but not PKC λ / ι , expression is downregulated by TGF in the loss

[1]  Y. Cho,et al.  Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer , 2020, Nature Genetics.

[2]  S. Lowe,et al.  Zonation of Ribosomal DNA Transcription Defines a Stem Cell Hierarchy in Colorectal Cancer. , 2020, Cell stem cell.

[3]  Y. Kluger,et al.  Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche , 2020, Nature.

[4]  R. Jain,et al.  A framework for advancing our understanding of cancer-associated fibroblasts , 2020, Nature Reviews Cancer.

[5]  A. Vincent-Salomon,et al.  Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms , 2020, Nature Communications.

[6]  J. Moscat,et al.  Serrated Colorectal Cancer: The Road Less Travelled? , 2019, Trends in cancer.

[7]  O. De Wever,et al.  Fibroblasts Fuel Immune Escape in the Tumor Microenvironment. , 2019, Trends in cancer.

[8]  D. Adams,et al.  Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis , 2019, Cancer cell.

[9]  J. Moscat,et al.  The Dual Roles of the Atypical Protein Kinase Cs in Cancer. , 2019, Cancer cell.

[10]  Jianmin Wu,et al.  Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment* , 2019, Molecular & Cellular Proteomics.

[11]  R. DePinho,et al.  KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer. , 2019, Cancer cell.

[12]  Weiqi Wang,et al.  Taiji: System-level identification of key transcription factors reveals transcriptional waves in mouse embryonic development , 2019, Science Advances.

[13]  A. Durán,et al.  Simultaneous Loss of Both Atypical Protein Kinase C Genes in the Intestinal Epithelium Drives Serrated Intestinal Cancer by Impairing Immunosurveillance , 2018, Immunity.

[14]  Zhenqiu Liu,et al.  Heterogeneous cancer associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner , 2018, Oncogene.

[15]  A. Durán,et al.  The Secretion of miR-200s by a PKCζ/ADAR2 Signaling Axis Promotes Liver Metastasis in Colorectal Cancer , 2018, Cell reports.

[16]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[17]  R. Bourgon,et al.  TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells , 2018, Nature.

[18]  A. Nebreda,et al.  TGF ‐ beta drives immune evasion in genetically reconstituted colon cancer metastasis , 2018 .

[19]  Christian M. Metallo,et al.  ATF4-Induced Metabolic Reprograming Is a Synthetic Vulnerability of the p62-Deficient Tumor Stroma. , 2017, Cell metabolism.

[20]  F. Marincola,et al.  Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications , 2017, International journal of molecular sciences.

[21]  Hui-Li Qu,et al.  Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer both In Vitro and In Vivo by Reversing Epithelial-Mesenchymal Transition , 2017, Cellular Physiology and Biochemistry.

[22]  Francisco J. Sánchez-Rivera,et al.  In vivo genome editing and organoid transplantation models of colorectal cancer , 2017, Nature Biotechnology.

[23]  J. Guinney,et al.  Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer , 2017, Nature Reviews Cancer.

[24]  H. Ikeuchi,et al.  Control of Paneth Cell Fate, Intestinal Inflammation, and Tumorigenesis by PKCλ/ι. , 2016, Cell reports.

[25]  L. Cantley,et al.  Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion , 2016, Nature.

[26]  R. Kalluri The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[27]  F. Markowetz,et al.  Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry , 2016, Clinical Cancer Research.

[28]  Etienne Becht,et al.  Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy , 2016, Clinical Cancer Research.

[29]  L. Ferrucci,et al.  sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance , 2016, Nature.

[30]  Ying Jin,et al.  Comprehensive profiling reveals mechanisms of SOX2-mediated cell fate specification in human ESCs and NPCs , 2016, Cell Research.

[31]  Jianqing Xu,et al.  SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment , 2016, Oncogene.

[32]  Jeffrey S. Morris,et al.  The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.

[33]  Camille Stephan-Otto Attolini,et al.  Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.

[34]  A. Durán,et al.  Repression of Intestinal Stem Cell Function and Tumorigenesis through Direct Phosphorylation of β-Catenin and Yap by PKCζ. , 2015, Cell reports.

[35]  Christian M. Metallo,et al.  Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. , 2014, Cancer cell.

[36]  Yan-xia Lu,et al.  Regulation of Colorectal Carcinoma Stemness, Growth, and Metastasis by an miR-200c-Sox2–Negative Feedback Loop Mechanism , 2014, Clinical Cancer Research.

[37]  M. Walsh,et al.  The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. , 2014, Cancer cell.

[38]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[39]  Florian Markowetz,et al.  Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions , 2013, Nature Medicine.

[40]  Aleksey A. Porollo,et al.  Control of Nutrient Stress-Induced Metabolic Reprogramming by PKCζ in Tumorigenesis , 2013, Cell.

[41]  K. Hochedlinger,et al.  The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. , 2013, Cell stem cell.

[42]  M. Nieto,et al.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.

[43]  Fabian J Theis,et al.  A Unilateral Negative Feedback Loop Between miR-200 microRNAs and Sox2/E2F3 Controls Neural Progenitor Cell-Cycle Exit and Differentiation , 2012, The Journal of Neuroscience.

[44]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[45]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[46]  M. Kazanietz,et al.  Protein kinase C and other diacylglycerol effectors in cancer , 2007, Nature Reviews Cancer.

[47]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[48]  O. Franco,et al.  Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. , 2005, Cancer research.

[49]  R. Derynck,et al.  Repression of Runx2 function by TGF‐β through recruitment of class II histone deacetylases by Smad3 , 2005, The EMBO journal.

[50]  T. Ratliff TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004 .

[51]  J. Massagué,et al.  E2F4/5 and p107 as Smad Cofactors Linking the TGFβ Receptor to c-myc Repression , 2002, Cell.

[52]  A. Durán,et al.  Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. , 2001, Molecular cell.